• SENSEX 76,917.85
    1,225.07 (+1.62%)
  • BANKNIFTY 55,540.05
    537.85 (+0.98%)
Back

Corporate News

AstraZeneca India confirms compliance with SEBI regulations for the quarter ending September 30, 2026
27-Oct-2026, 01:45

AstraZeneca Pharma India Limited informed the BSE Limited and National Stock Exchange of India Ltd. that Integrated Registry Management Services Private Limited, its Registrar and Transfer Agent, has confirmed compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026.